Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 383

1.

[PRIMARY BILIARY CHOLANGITIS: THERAPEUTIC APPROACH IN THE MODERN ERA].

Abu Backer F, Abu Mouch S, Mari A.

Harefuah. 2018 Dec;157(12):791-796. Review. Hebrew.

PMID:
30582314
2.

Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.

Hou Y, Liu M, Luo YB, Sun Y, Shao K, Dai T, Li W, Zhao Y, Yan C.

Neuromuscul Disord. 2018 Nov 22. pii: S0960-8966(17)31487-6. doi: 10.1016/j.nmd.2018.11.004. [Epub ahead of print]

3.

Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.

Moritoki Y, Tsuneyama K, Nakamura Y, Kikuchi K, Shiota A, Ohsugi Y, Lian ZX, Zhang W, Yang GX, Ueki S, Takeda M, Omokawa A, Saga T, Saga A, Watanabe D, Miura M, Ueno Y, Leung PSC, Tanaka A, Gershwin ME, Hirokawa M.

Front Immunol. 2018 Nov 2;9:2534. doi: 10.3389/fimmu.2018.02534. eCollection 2018.

4.

Comorbidity of localized scleroderma and primary biliary cholangitis.

Bali G, Szilvási A, Inotai D, Varga Á, Sárdy M, Kárpáti S, Medvecz M, Szegedi A, Hidvégi B.

J Dtsch Dermatol Ges. 2018 Nov;16(11):1323-1327. doi: 10.1111/ddg.13693.

PMID:
30395408
5.

Pathophysiology of primary biliary cholangitis.

Gulamhusein AF, Hirschfield GM.

Best Pract Res Clin Gastroenterol. 2018 Jun - Aug;34-35:17-25. doi: 10.1016/j.bpg.2018.05.012. Epub 2018 May 24. Review.

PMID:
30343706
6.

Changes in the Epidemiology of Primary Biliary Cholangitis.

Lleo A, Colapietro F.

Clin Liver Dis. 2018 Aug;22(3):429-441. doi: 10.1016/j.cld.2018.03.001. Review.

PMID:
30259845
7.

Adipokine interactions promote the pathogenesis of systemic lupus erythematosus.

Chougule D, Nadkar M, Venkataraman K, Rajadhyaksha A, Hase N, Jamale T, Kini S, Khadilkar P, Anand V, Madkaikar M, Pradhan V.

Cytokine. 2018 Nov;111:20-27. doi: 10.1016/j.cyto.2018.08.002. Epub 2018 Aug 8.

PMID:
30098476
8.

A study of prevalence of autoantibodies in patients with lichen planus from Mumbai, India.

Rambhia KD, Kharkar V, Pradhan V, Patwardhan M, Ghosh K, Khopkar US.

Indian J Dermatol Venereol Leprol. 2018 Nov-Dec;84(6):667-671. doi: 10.4103/ijdvl.IJDVL_182_17.

9.

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.

Rose S, Niyazov DM, Rossignol DA, Goldenthal M, Kahler SG, Frye RE.

Mol Diagn Ther. 2018 Oct;22(5):571-593. doi: 10.1007/s40291-018-0352-x. Review.

10.

Vitiligo and autoantibodies: a systematic review and meta-analysis.

Liu CW, Huang YC.

J Dtsch Dermatol Ges. 2018 Jul;16(7):845-851. doi: 10.1111/ddg.13574. Epub 2018 Jul 4. Review.

PMID:
29972626
11.

A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity.

Nguyen HH, Khathlan A, Fritzler MJ, Swain MG.

BMC Gastroenterol. 2018 Jun 25;18(1):97. doi: 10.1186/s12876-018-0826-7.

12.

Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure.

Anastasiou OE, Dogan-Cavus B, Kucukoglu O, Baba H, Kahraman A, Gerken G, Schramm C, Canbay A.

Digestion. 2018;98(2):104-111. doi: 10.1159/000487940. Epub 2018 Apr 26.

PMID:
29698940
13.

Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.

Ceribelli A, Isailovic N, De Santis M, Selmi C.

Semin Arthritis Rheum. 2018 Mar 28. pii: S0049-0172(18)30153-7. doi: 10.1016/j.semarthrit.2018.03.014. [Epub ahead of print] No abstract available.

PMID:
29685483
15.

Anti-mitochondrial M2 Antibodies and Myopathy.

Finsterer J, Zarrouk-Mahjoub S.

Intern Med. 2018 Apr 15;57(8):1187. doi: 10.2169/internalmedicine.9878-17. Epub 2017 Dec 27. No abstract available.

16.

A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization.

Ma WT, Liu QZ, Yang JB, Yang YQ, Zhao ZB, Ma HD, Gershwin ME, Lian ZX.

Sci Rep. 2017 Nov 10;7(1):15246. doi: 10.1038/s41598-017-15661-6.

17.

Less Limb Muscle Involvement in Myositis Patients with Anti-Mitochondrial Antibodies.

Uenaka T, Kowa H, Ohtsuka Y, Seki T, Sekiguchi K, Kanda F, Toda T.

Eur Neurol. 2017;78(5-6):290-295. doi: 10.1159/000481503. Epub 2017 Oct 19.

PMID:
29049993
18.

Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis.

Ceribelli A, Isailovic N, De Santis M, Generali E, Satoh M, Selmi C.

J Immunol Methods. 2018 Jan;452:1-5. doi: 10.1016/j.jim.2017.10.001. Epub 2017 Oct 4.

PMID:
28986201
19.

Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.

Albayda J, Khan A, Casciola-Rosen L, Corse AM, Paik JJ, Christopher-Stine L.

Semin Arthritis Rheum. 2018 Feb;47(4):552-556. doi: 10.1016/j.semarthrit.2017.06.004. Epub 2017 Jun 13.

PMID:
28893408
20.

Circulating follicular helper T cells presented distinctively different responses toward bacterial antigens in primary biliary cholangitis.

Zhou ZQ, Tong DN, Guan J, Li MF, Feng QM, Zhou MJ, Zhang ZY.

Int Immunopharmacol. 2017 Oct;51:76-81. doi: 10.1016/j.intimp.2017.08.004. Epub 2017 Aug 12.

PMID:
28806642

Supplemental Content

Loading ...
Support Center